CliffBio

Mayne Pharma

Patent cliffs & loss of exclusivity

Specialty, Generics

Company

Crunchbase URLhttps://www.crunchbase.com/organization/mayne-pharma
LinkedIn URLhttps://www.linkedin.com/company/mayne-pharma
Official Websitehttp://maynepharma.com

12 upcoming patent cliffs

DrugIngredientTypeCliff
  1. SORILUXCALCIPOTRIENESmall mol.May 2028
  2. FABIORTAZAROTENESmall mol.Feb 2030
  3. BIJUVAESTRADIOL; PROGESTERONESmall mol.Nov 2032
  4. BIJUVAESTRADIOL; PROGESTERONESmall mol.Nov 2032
  5. IMVEXXYESTRADIOLSmall mol.Feb 2034
  6. IMVEXXYESTRADIOLSmall mol.Feb 2034
  7. RHOFADEOXYMETAZOLINE HYDROCHLORIDESmall mol.Jun 2035
  8. LEXETTEHALOBETASOL PROPIONATESmall mol.May 2037
  9. ANNOVERAETHINYL ESTRADIOL; SEGESTERONE ACETATESmall mol.Jun 2039
  10. EPSOLAYBENZOYL PEROXIDESmall mol.May 2041
  11. TWYNEOBENZOYL PEROXIDE; TRETINOINSmall mol.May 2041
  12. NEXTSTELLISDROSPIRENONE; ESTETROLSmall mol.Oct 2043
  13. FENTANYL-100FENTANYLSmall mol.—
  14. FENTANYL-25FENTANYLSmall mol.—
  15. FENTANYL-50FENTANYLSmall mol.—
  16. FENTANYL-75FENTANYLSmall mol.—
  17. HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDEHYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDESmall mol.—
  18. HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDECHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.